WebNov 10, 2024 · Deborah M. Rothman, PhD, has been a Director of Chemical Biology within Discovery Chemistry at Merck & Co since late 2016. In her role, she is responsible for … WebDeborah M. Rothman, PhD, has been a Director of Chemical Biology within Discovery Chemistry at Merck & Co since late 2016. In her role, she is responsible for developing …
Merck Home
WebDr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry, including his positions as the CEO of Johns Hopkins Medicine and the dean of Medical Faculty and vice … WebOn March 22, 2007, a Petition for Advisory Opinion was received from Deborah Rothman as Trustee of the X Trust Agreement dated May 15, 1985, as amended, c\o Bruce Mac Corkindale, CPA. P.C., 3960 Merrick Road, Seaford, New York 11783. The issue raised by Petitioner, Deborah Rothman, as Trustee of the X Trust Agreement, pse shootdown 2018
Dr. Deborah Rothman, MD Boston, MA - US News Health
WebChief executive officer and director (2006-2008) Chairman, Lucent Technologies Inc. (2003-2006) President and chief executive officer, Lucent Technologies Inc. (2002-2006) More of our board of directors Meet the diverse team who guide our company's direction and strategy. View all board of directors slide 7 to 8 of 4 Kathy J. Warden WebBiography of Robert Davis. Mr. Robert M. Davis is an Independent Director at Duke Energy Corp., a President at Merck & Co., Inc. and a Chairman at Gambro AB. He is on the Board of Directors at Duke Energy Corp., AdvaMedDx, Project HOPE-The-People-To-People HealthFoundation, Inc. and Rush University Medical Center. Mr. WebMar 21, 2024 · Deb Rothman, (Merck, USA) Sarah Teichmann (University of Cambridge, UK) Andrew Leach (EBI, Cambridge, UK) Ian Storer (AstraZeneca, Cambridge, UK) Paul Brennan (University of Oxford, UK) Find out more from the SMR Category: External events Check our related events Back to Events pse shootdown 2019